| Editor's Choice: Leadership | Justine Varieur Turco held several leadership positions with the American College of Cardiology over the years. She is also a former Cardiovascular Business editor. Justine Varieur Turco held several leadership positions with the American College of Cardiology over the years. She is also a former Cardiovascular Business editor. | | |
| A multidisciplinary committee formed in 2022 to identify ways to improve safety and efficiency in their facility's cath lab. By 2024, it was clear the group's proposals had made a major impact. A multidisciplinary committee formed in 2022 to identify ways to improve safety and efficiency in their facility's cath lab. By 2024, it was clear the group's proposals had made a major impact. | | |
| Veteran cardiologist Jonathan Reiner, MD, a professor at George Washington University, shared his concerns about President Donald Trump's health. Veteran cardiologist Jonathan Reiner, MD, a professor at George Washington University, shared his concerns about President Donald Trump's health. | | |
| Mohamad Alkhouli, MD, MBA, a professor of medicine at Mayo Clinic School of Medicine and practicing cardiologist, has been named the next editor-in-chief of JACC: Cardiovascular Interventions. Mohamad Alkhouli, MD, MBA, a professor of medicine at Mayo Clinic School of Medicine and practicing cardiologist, has been named the next editor-in-chief of JACC: Cardiovascular Interventions. | | |
| Robert L. Frye, MD, spent more than 60 years with Mayo Clinic. He was also a former president of the American College of Cardiology. Robert L. Frye, MD, spent more than 60 years with Mayo Clinic. He was also a former president of the American College of Cardiology. | | |
| Robert Califf, MD, MACC, a veteran cardiologist, delivered the keynote speech at SCCT 2026 and then spoke to Cardiovascular Business about where the country's healthcare system is headed. Robert Califf, MD, MACC, a veteran cardiologist, delivered the keynote speech at SCCT 2026 and then spoke to Cardiovascular Business about where the country's healthcare system is headed. | | |
| Bill Shields, who spent a 15 years with Medtronic’s structural heart division, will now be helping lead a startup focused on tricuspid valve treatments. Bill Shields, who spent a 15 years with Medtronic’s structural heart division, will now be helping lead a startup focused on tricuspid valve treatments. | | |
| | |
|
| ![]() | |
|
